Sheng-Bin Peng Selected Research

Sheng-Bin Peng Research Topics

Disease

21	Neoplasms (Cancer) 10/2020 - 02/2005
5	Melanoma (Melanoma, Malignant) 01/2020 - 08/2012
4	Neoplasm Metastasis (Metastasis) 10/2020 - 11/2005
4	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 02/2017
3	Carcinogenesis 01/2016 - 11/2005
3	Breast Neoplasms (Breast Cancer) 02/2015 - 03/2004
2	Lymphoma (Lymphomas) 01/2016 - 02/2015
1	Nausea 01/2020
1	Exanthema (Rash) 01/2020
1	Fatigue 01/2020
1	Dermatitis 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 03/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Leukemia 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2015
1	Colonic Neoplasms (Colon Cancer) 02/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2015
1	Hypertension (High Blood Pressure) 11/2011
1	Pathologic Processes 11/2005
1	Carcinoma (Carcinomatosis) 04/2005
1	Fibrosis (Cirrhosis) 02/2005

Drug/Important Bio-Agent (IBA)

6	LY3009120IBA 01/2020 - 05/2015
5	Pharmaceutical PreparationsIBA 01/2020 - 09/2008
5	Phosphotransferases (Kinase)IBA 03/2016 - 04/2005
4	LY2510924IBA 01/2020 - 02/2015
4	VemurafenibIBA 03/2016 - 08/2012
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2005
3	Chemokine ReceptorsIBA 01/2016 - 11/2005
3	ChemokinesIBA 01/2016 - 09/2008
2	Peptides (Polypeptides)IBA 01/2020 - 11/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2020
2	LY2624587IBA 11/2017 - 01/2016
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2015 - 10/2014
2	Cyclin D1IBA 05/2015 - 10/2014
2	Chemokine CXCL12IBA 02/2015 - 04/2005
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 08/2012 - 11/2011
2	Biological ProductsIBA 09/2008 - 11/2005
2	Proteins (Proteins, Gene)FDA Link 04/2005 - 03/2004
1	MicroRNAs (MicroRNA)IBA 10/2020
1	LY3214996IBA 01/2020
1	durvalumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 11/2017
1	Cetuximab (Erbitux)FDA Link 09/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Guanosine Triphosphate (GTP)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 09/2015
1	CXC ChemokinesIBA 07/2015
1	Urea (Carbamide)FDA LinkGeneric 05/2015
1	dabrafenibIBA 05/2015
1	Cyclic PeptidesIBA 02/2015
1	abemaciclibIBA 10/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Ligases (Synthetase)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Histone MethyltransferasesIBA 01/2014
1	UbiquitinIBA 01/2014
1	Mitogen-Activated Protein KinasesIBA 08/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2011
1	2- (4- (2- (5- (1- (3,5- dichloropyridin- 4- yl)ethoxy)- 1H- indazol- 3yl)vinyl)- 1H- pyrazol- 1- yl)ethanolIBA 11/2011
1	Tyrosine (L-Tyrosine)FDA Link 11/2011
1	NF-kappa B (NF-kB)IBA 09/2008
1	Epidermal Growth Factor (EGF)IBA 09/2008
1	Lysophosphatidic Acid ReceptorsIBA 11/2005
1	Neuropeptide Receptors (Neuropeptide Receptor)IBA 11/2005
1	Calcium-Sensing ReceptorsIBA 11/2005
1	Purinergic P2Y ReceptorsIBA 11/2005
1	Proteinase-Activated ReceptorsIBA 11/2005
1	Adenosine A2B ReceptorIBA 11/2005
1	Endothelin Receptors (Endothelin Receptor)IBA 11/2005
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2005
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 11/2005
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 04/2005
1	MitogensIBA 04/2005
1	LigandsIBA 04/2005
1	WortmanninIBA 04/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2005
1	U 0126 (UO 126)IBA 04/2005
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 04/2005
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2005
1	PyrazolesIBA 02/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2005
1	LY 475776IBA 03/2004

Therapy/Procedure

5	Therapeutics 01/2020 - 10/2014
1	Precision Medicine 01/2020
1	Drug Therapy (Chemotherapy) 09/2008